Disease modifying agents capable of controlling obesity with meaningful metabolic improvement have reshaped expectations for both clinicians and patients ( Nausea and vomiting remain among the most frequent and disruptive adverse effects across Glucagon-like peptide (GLP-1)-based therapies ( In this opinion article, we examine the mechanisms underlying nausea and vomiting in semaglutide, CagriSema, survodutide, tirzepatide, retatrutide, and orforglipron and situate them within obesity clinical practice ( We also propose practical strategies to mitigate gastrointestinal intolerance
Evidence-based dCBT-I programs typically combine techniques like sleep hygiene, sleep restriction, stimulus control, relaxation or mindfulness, and cognitive therapy over several weeks 9,10
Our tirzepatide dose chart provides the conversion tables
Our cult-favorite aesthetic protocol, built around GHK-Cu copper peptide and regenerative support
PRODUCT INFORMATION Introducing DSIP, the Delta Sleep-Inducing Peptide, known for its potential to improve sleep quality and promote relaxation
